CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in VRAY, MDP, and MGNX of Filing Deadlines
GlobeNewswire

NEW YORK, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of VRAY, MDP, and MGNX. If you wish to serve as lead plaintiff, you must move the court by the lead plaintiff deadlines listed below. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you take no action, you may remain an absent class member. 

To discuss the cases below please contact Matthew E. Guarnero toll free at (877) 779-1414.

ViewRay (NASDAQ:VRAY)

CLASS PERIOD:
03/15/2019 - 08/08/2019

LEAD PLAINTIFF DEADLINE: November 12, 2019

Defendants failed to disclose to investors that: (i) demand for ViewRay systems had declined due in part to changes being made to Medicare reimbursement approaches first announced in November 2019 that could make purchases of new ViewRay systems less profitable for customers; (ii) the Company’s reported backlog was overstated due to the inclusion of orders with insufficient surety as to permit for their inclusion in reported backlog; and (iii) as a result of the foregoing, defendant’s positive statements about ViewRay’s business metrics and financial prospects during the Class Period were materially false and misleading and/or lacked a reasonable basis.

To get additional information about the ViewRay Shareholder Class Action contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com

Meredith Corporation (NYSE: MDP)

CLASS PERIOD:
01/31/2018 - 09/05/2019

LEAD PLAINTIFF DEADLINE: November 5, 2019

Defendants failed to disclose to investors that: (i) the Time, Inc. acquisition was not as profitable as the Company had claimed; (ii) the Company would incur additional costs for strategic investments to improve the Time business; (iii) as a result, the Company’s earnings would be materially and adversely impacted; and (iv) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To get additional information about the Meredith Corp. Shareholder Class Action contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com

MacroGenics, Inc  (NASDAQ: MGNX)

CLASS PERIOD:
02/06/2019-06/03/2019

LEAD PLAINTIFF DEADLINE: November 12, 2019

Defendants concealed material information and/or failed to disclose that: (a) the Company had conducted the progression-free survival (PFS) and first interim overall survival (OS) analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves (a non-parametric statistic used to estimate the survival function from lifetime data) crossed in several spots (thereby violating the constant hazard assumption) and separated late.

To get additional information about the MacroGenics Shareholder Class Action contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP

http://www.bernlieb.com  

(877) 779-1414

MGuarnero@bernlieb.com

© Alipes Capital ApS 2012